Yubo International Biotech Limited

YBGJ ·Healthcare, Medical Devices, China
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011
Operating Activities
Net Income $-224.0K $-130.0K $-116.0K $-106.0K $-103.0K $-84.0K $-110.0K
Depreciation & Amortization — — — — — — —
Depreciation — — — — — — —
Amortization — — — — — — —
Stock-Based Compensation — — — — — — —
Net Cash from Operating Activities $-55.0K $-56.0K $-63.0K $-46.0K $-38.0K $-43.0K $-49.0K
Investing Activities
Capital Expenditures — — — — — — —
Business Acquisitions — — — — — — —
Net Cash from Investing Activities $0 — — — — — —
Financing Activities
Dividends Paid — — — — — — —
Stock Repurchases — — — — — — —
Net Cash from Financing Activities $45.0K $55.0K — — — — —
Net Change in Cash $-10.0K $-1.0K $4.0K $-4.0K $5.0K $0 $1.0K
Free Cash Flow — — — — — — —
← Newer Page 2 of 2 Older →